Efficacy and toxicity of radiation in preparative regimens for pediatric stem cell transplantation. II: Deleterious consequences

Medical Oncology

Volumn 13, Issue 1, 1996, Pages 43-61

  Miale, Thomas D ^a,c   Sirithorn, Suebsuk ^a,b   Ahmed, Syed ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^b BHUMIBOL ADULYADEJ HOSPITAL   (Thailand)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

bone marrow transplantation; busulfan; cyclophosphamide; pediatrics; stem cells; total body irradiation

Indexed keywords

BUSULFAN; CD34 ANTIGEN; COLONY STIMULATING FACTOR; CYTARABINE; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6; MELPHALAN; NEUTRALIZING ANTIBODY; STEM CELL FACTOR; THROMBOPOIETIN;

CLINICAL ARTICLE; CONTROLLED STUDY; EYE TOXICITY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; NEUROPSYCHOLOGY; PRIORITY JOURNAL; RADIATION MONITORING; REVIEW; STEM CELL TRANSPLANTATION; TOXICITY TESTING; VEIN OCCLUSION;

EID: 0029793683     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02988840     Document Type: Review

References (130)

1. Psiachou, E., Hann, I.M., Morgan, G. and Chessells, J.M. (1994) Early deaths in children undergoing marrow ablative therapy and bone marrow transplantation. Bone Marrow Transplant. 14, 975-80.
2. Miller, R.W. (1995) Special susceptibility of the child to certain radiation-induced cancers. Environ. Health Perspect. 103 (Suppl 6), 41-4.
3. Miale, T.D. and Kirpekar, K. (1994) Neuroblastoma stage IV-S. Med. Oncol. 11, 89-100.
4. Valls, A., Granena, A., Carreras, E., Ferrer, E. and Algara, M. (1989) Total body irradiation in bone marrow transplantation: fractionated vs. single dose. Acute toxicity and preliminary results. Bull. Cancer 76, 797-804.
5. Kim, T.H., McGlave, P.B., Ramsay, N., Woods, W., Boström, B., Vercellotti, G., Hurd, D., Krivit, W., Nesbit, M., Haake, R., Kahn, F. and Kersey, J.M. (1990) Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. Int. J. Radiat. Oncol. Biol. Phys. 19, 889-97.
6. Socie, G., Devergie, A., Girinsky, T., Reiffers, J., Vernant, J.P., Le Bourgeois, J.P., Herve, P., Guyotat, D., Maraninchi, D., Rio, B., Michallet, M., Jouet, J.P., Milplied, N., Leblond, V., Pico, J., Attal, M., Belanger, C., Gluckman, E. and Cosset, J.M. (1991) Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukaemia. The Groupe d'Etude des greffes de moelle osseuse (GEGMO). Int. J. Radiat. Oncol. Biol. Phys. 20, 397-404.
7. Tutschka, P.J., Copelan, E.A. and Klein, J.P. (1987) Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 70, 1382-8.
8. Tutschka, P.J., Copelan, E.A. and Kapoor, N. (1989) Replacing total body irradiation with busulfan as conditioning of patients with leukemia for allogeneic marrow transplantation. Transplant. Proc. 21, 2952-4.
9. Tutschka, P.J., Copelan, E.A., Kapoor, N., Avalos, B.R. and Klein, J.P. (1991) Allogeneic bone marrow transplantation for leukemia using chemotherapy as conditioning: 6 year results of a single institution trial. Transplant. Proc. 23, 1709-10.
10. Tutschka, P.J. (1993) Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting. Bone Marrow Transplant. 12, 34-6.
11. Tait, R.C., Burnett, A.K., Robertson, A.G., McNee, S., Riyami, B.M.S., Carter, R. and Stevenson, R.D. (1991) Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: relationship to total body irradiation and graft-versus-host disease. Int. J. Rad. Oncol. Biol. Phys. 20, 1219-27.
12. Crilley, P., Topolsky, D., Styler, M.J., Bernstein, E., Resnick, K., Mullaney, R., Bulova, S., Brodsky, I. and Marks, D.I. (1995) Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogeneic bone marrow transplantation. Bone Marrow Transplant. 15, 361-6.
13. Garaventa, A., Rondelli, R., Castagnola, E., Locatelli, F., Dallorso, S., Porta, F., Uderzo, C., Rosetti, F., Miniero, R., Andolina, M., Amici, A., Iori, A.P., Di Bartolomeo, P., Dini, G., Pession, A., Paolucci, P. and Viscoli, C. (1993) Fatal pneumopathy in children after bone marrow transplantation-report from the Italian Registry. Bone Marrow Transplant. 16, 669-74.
14. Pihkala, J., Saarinen, U.M., Lundström, U., Salmo, M., Virkola, K., Virtanen, K., Siimes, M.A. and Pesonen, E. (1994) Effects of bone marrow transplantation on myocardial function in children. Bone Marrow Transplant. 13, 149-55.
15. Vitale, V. and Franzone, P. (1991) The role of TBI in conditioning regimens for children. Bone Marrow Transplant. 7, 32-4.
16. Vitale, V., Barra, S. and Franzone, P. (1991) Total body irradiation in the conditioning regimen for hematological malignancies. Bone Marrow Transplant. 8, 28-9.
17. Calissendorff, B., Bolme, P. and El Azazi, M. (1991) The development of cataract in children as a late side-effect of bone marrow transplantation. Bone Marrow Transplant. 7, 427-9.
18. Tichelli, A., Gratwohl, A., Egger, T., Roth, J., Prunte, A., Nissen, C. and Speck, B. (1993) Cataract formation after bone marrow transplantation. Ann. Int. Med. 119, 1175-80.
19. Dunn, J.P., Jabs, D.A., Wingard, J., Enger, C., Vogelsang, G. and Santos, G. (1993) Bone marrow transplantation and cataract development. Arch. Ophthalmol. 111, 1367-73.
20. Ozashin, M., Belkacemi, Y., Pene, F., Dominique, C., Schwartz, L.H., Uzal, C., Lefkipoulos, D., Gindrey-Vie, B., Vitu-Loas, L., Touboul, E., Schlienger, M. and Laugier, A. (1994) Total-body irradiation and cataract incidence: a randomized comparison of two instantaneous dose rates. Int. J. Rad. Oncol. Biol. Phys. 28, 343-7.
21. Shaw, P.J., Scharping, C.E., Brian, R.J. and Earl, J.W. (1994) Busulfan pharmacokinetics using a single daily high-dose regimen in children with acute leukemia. Blood 84, 2357-62.
22. Shaw, P.J., Bergin, M.E., Burgess, M.A., Dalla Pozza, L., Kellie, S.J., Rowell, G., Stevens, M.M., Webster, B.H. and Bradstock, K.F. (1994) Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation. J. Clin. Oncol. 12, 2138-45.
23. Attal, M., Huguet, F., Rubie, H., Huynh, A., Charlet, J.-P., Payen, J.-L., Voigt, J.-J., Brousset, P., Selves, J., Muller, C., Pris, J. and Laurent, G. (1992) Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low dose heparin: A prospective, randomized trial. Blood 79, 2834-40.
24. Bearman, S.I. (1995) The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 85, 3005-20.
25. Schriber, J., Christiansen, N., Baer, M.R., Slack, J., Wetzler, M. and Herzig, G. (1995) Tissue plasminogen activator as therapy for hepatotoxicity following bone marrow transplantation (abstr. 869). Blood 86, 220-2.
26. Sanders, J.E. (1991) Endocrine problems in children after bone marrow transplant for hematologic malignancies. Bone Marrow Transplant. 8, 2-4.
27. Borgström, B. and Bolme, P. (1994) Thyroid function in children after allogeneic bone marrow transplantation. Bone Marrow Transplant. 13, 59-64.
28. Shalet, S.M., Didi, M., Ogilvy-Stuart, A.L., Schulga, J. and Donaldson, M.D.C. (1995) Growth and endocrine function after bone marrow transplantation. Clin. Endocrinol. 42, 333-59.
29. Fletcher, B.D., Crom, D.B., Krance, R.A. and Kun, L.E. (1994) Radiation-induced bone abnormalities after bone marrow transplantation for childhood leukemia. Radiology 191, 231-35.
30. Dahllof, G., Krekmanova, L., Kopp, S., Borgström, B., Forsberg, C.M. and Ringdén, O. (1994) Craniomandibular dysfunction in children treated with total-body irradiation and bone marrow transplantation. Acta Odontolog. Scand. 52, 99-105.
31. Pot-Mees, C.C. (1989) The Physiological Aspects of Bone Marrow Transplantation in Children, Delft: Eburon.
32. Kramer, J.H., Crittenden, M.R., Halberg, F.E., Wara, W.M. and Cowan, M.J. (1992) A prospective study of cognitive functioning following low-dose cranial radiation for bone marrow transplantation. Pediatr. 90, 447-50.
33. Phipps, S., Brenner, M., Heslop, H., Krance, R., Jayawardene, D. and Mulhern, R. (1995) Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study. Bone Marrow Transplant. 15, 829-35.
34. Clift, R.A., Buckner, C.D., Thomas, E.D., Bensinger, W.I., Bowden, R., Bryant, E., Deeg, H.J., Doney, K.C., Fisher, L.D., Hansen, J.A., Martin, P., McDonald, G.B., Sanders, J.E., Schoch, G., Singer, J., Storb, R., Sullivan, K.M., Witherspoon, R.P. and Appelbaum, F.R. (1994) Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 84, 2036-43.
35. Ringdén, O., Ruutu, T., Remberger, M., Nikoskelainen, J., Volin, L., Vindelov, L., Parkkali, T., Lenhoff, S., Sallerfors, B., Ljungman, P., Mellander, L. and Jacobsen, N. (1994) A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 83, 2723-30.
36. Dusenbery, K., Daniels, K., McClure, J., McGlave, P., Ramsay, N., Kersey, J. and Woods, W. (1994) Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia (abstr.). Proc ASCO. 13 p. 310. Dallas TX: Saunders.
37. Michel, G., Gluckman, E., Esperou-Bourdeau, H., Reiffers, J., Pico, J.L., Bordigoni, P., Thuret, I., Biaise, D., Bernaudin, F., Jouet, J.P., Lemerle, S., Rubie, H., Milpied, N., Vannier, J.P., Demeocq, F., Troussard, X., Gratecos, N., Plouvier, E., Bergeron, C., Gardembas, M., Gouvernet, J. and Maraninchi, D. (1994) Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation-a report from the Societe Francaise de Greffe de Moelle. J. Clin. Oncol. 12, 1217-22.
38. Morgan, M., Dodds, A., Atkinson, K., Szer, J., Downs, K. and Biggs, J. (1991) The toxicity of busulfan and cyclophosphamide as the preparative regimen for bone marrow transplantation. Br. J. Haematol. 77, 529-34.
39. Piedbois, P., Ganem, G., Cordonnier, C., Levy, C., Benk, V., Pavlovitch, J.M., Saint-Marc Giradin, M.F., Kuentz, M., Marinello, G., Mazeron, J.J., Dhumeaux, D., Vernant, J.P. and Le Bourgeois, J.P. (1990) Interstitial pneumonitis and venocclusive disease of the liver after bone marrow transplantation. Radiother. Oncol. 18 (suppl 1), 125-7.
40. Spitzer, T.R., Peters, C., Ortlieb, M., Tefft, M.C., Torrisi, J., Cahill, R., Gadner, H., Urban, C. and Deeg, H.J. (1994) Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and children. Int. J. Rad. Oncol. Biol. Phys. 29, 39-44.
41. Brodsky, I., Bulova, S. and Crilley, P. (1989) The role of busulfan/cyclophosphamide regimens in allogeneic and autologous bone marrow transplantation. Cancer. Invest. 7, 509-13.
42. Brodsky, R., Topolsky, D., Crilley, P., Bulova, S. and Brodsky, I. (1990) Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan/cyclophosphamide preparative regimen. Am. J. Clin. Oncol. 13, 221-5.
43. Kasai, M., Kiyama, Y., Watanabe, M., Seto, K., Matsuura, A., Tanaka, J., Takeda, H., Naohara, T., Higa, T., Hashino, S., Kobayashi, H., Kobayashi, M., Imamura, M., Sakurada, K. and Miyazaki, T. (1992) Toxicity of high-dose busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation. Transplant. Proc. 24, 1529-30.
44. Méresse, V., Hartmann, O., Vassal, G., Benhamou, E., Valteau-Couanet, D., Brugieres, L. and Lemerle, J. (1992) Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant. 10, 135-41.
45. Leiper, A.D., Stanhope, R., Lau, T., Grant, D.B., Blacklock, H., Chessells, J.M. and Plowman, P.N. (1987) The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br. J. Haematol. 67, 419-26.
46. Leiper, A.D. (1990) Management of growth failure in the treatment of malignant disease. Pediatr. Hematol. Oncol. 7, 365-71.
47. Keilholz, U., Körbling, M., Fehrentz, D., Bauer, H. and Hunstein, W. (1989) Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/ blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders. Cancer 64, 641-5.
48. van Weel-Sipman, M.H., van't Veer-Korthof, E.T., van den Berg, H., Gerritsen, E.J., Noordijk, E.M., Kamphuis, R.P. and Vossen, J.M. (1990) Late effects of total body irradiation and cytostatic preparative regimen for bone marrow transplantation in children with hematological malignancies. Radiother. Oncol. 18 (suppl 1), 155-7.
49. Halbert, F.E., Wara, W.M., Weaver, K.E., Wara, D.W., Ablin, A.R., Matthay, K.K., Mentzer, W.C., O'Leary, M.C. and Cowan, M.J. (1990) Total body irradiation and bone marrow transplantation for immunodeficiency disorders in young children. Radiother. Oncol. 18, 114-7.
50. Thuret, I., Michel, G., Carla, H., Chambost, H., Biaise, D., Demeocq, F. and Maraninchi, D. (1995) Long-term side-effects in children receiving allogeneic bone marrow transplantation in first complete remission of acute leukaemia. Bone Marrow Transplant. 15, 337-42.
51. Cohen, A., van-Lint, M.T., Uderzo, C., Rovelli, A., Lavagetto, A., Vitale, V., Morchio, A., Locasciulli, A., Bacigalupo, A. and Romano, C. (1995) Growth in patients after allogeneic bone marrow transplant for hematological diseases in childhood. Bone Marrow Transplant. 15, 343-8.
52. Urban, C., Schwingshandl, J., Slavc, I., Gamillscheg, A., Hauer, C., Schmid, G., Kaulfersch, W. and Borkenstein, M. (1988) Endocrine function after bone marrow transplantation without the use of preparative total body irradiation. Bone Marrow Transplant. 3, 291-6.
53. Shinohara, O., Kato, S., Yabe, H., Yabe, M., Kubota, C., Mitsuda, R. and Kimura, M. (1991) Growth after bone marrow transplantation in children. Am. J. Pediatr. Hematol. Oncol. 13, 263-8.
54. Adams, C., August, C.S., Maguire, H. and Sladky, J.T. (1995) Neuromuscular complications of bone marrow transplantation. Pediatr. Neurol. 12, 58-61.
55. Smedler, A.C., Ringdén, K., Bergman, H. and Bolme, P. (1990) Sensory-motor and cognitive function in children who have undergone bone marrow transplantation. Acta Paediatr. Scand. 79, 613-21.
56. Andrykowski, M.A., Altmaier, E.M., Barnett, R.L., Burish, T.G., Gingrich, R. and Henslee-Downey, P.J. (1990) Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: relationship to dose of total body irradiation. Bone Marrow Transplant. 6, 269-76.
57. Liesner, R.J., Leiper, A.D., Hann, I.M. and Chessells, J.M. (1994) Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in children. Clin. Oncol. 12, 916-24.
58. Hamon, M.D., Gale, R.F., MacDonald, I.D., Smith, O.P., Collis, C.H., Skeggs, D.B., Gandhi, L. and Prentice, H.G. (1993) Incidence of cataracts after single fraction total body irradiation: the role of steroids and graft versus host disease. Bone Marrow Transplant. 12, 233-6.
59. Uderzo, C., van Lint, M.T., Rovelli, A., Weber, G., Castellani, M.R., Bacigalupo, A., Masera, N. and Cohen, A. (1994) Papillary thyroid carcinoma after total body irradiation. Arch. Dis. Child. 71, 256-8.
60. Sanders, J.E. (1994) Late effects after bone marrow transplant. In C.L. Schwartz, W.L. Hobbie, L.S. Constine and K.S. Ruccione (eds) Survivors of Childhood Cancer: Assessment and Management, chap. 15, pp. 293-318. St. Louis: Mosby.
61. Boulad, F., Bromley, M., Black, P., Heller, G., Sarafoglou, K., Gillio, A., Papdopoulos, E. and Sklar, C. (1995) Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant. 15, 71-6.
62. Sklar, C. (1995) Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Pœdiatr, Suppl 411, 57-61.
63. Katsanis, E., Shapiro, R.S., Robinson, L.L., Haake, R.J., Kim, T. and Ramsay, N.K.C. (1990) Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients. Bone Marrow Transplant. 5, 335-40.
64. De Simone, M., Olioso, P., Di Bartolomeo, P., Di Girolamo, G., Farello, G., Palumbo, M., Papalinetti, G., Bavaro, P., Angrilli, F., Torlontano, G. and De Matteis, F. (1995) Growth and endocrine function following bone marrow transplantation for thalassemia. Bone Marrow Transplant. 15, 227-34.
65. Saaringen, H.L. and Simes, M.A. (1991) Growth failure in children after total body irradiation preparative for bone marrow transplantation. Bone Marrow Transplant. 8, 10-13.
66. Wingard, J.R., Plotnick, L.P., Freemer, C.S., Zahurak, M., Piantadosi, S., Miller, D.F., Vriesendorp, H.M. and Yeager, A.M. (1992) Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 79, 1068-73.
67. Sanders, J.E. (1995) Endocrine function and cardio-pulmonary status following pediatric marrow transplantation. In M.E. Trigg and F.L. Johnson (eds) Marrow Transplantation in Children: Current Results and Controversies, pp. 199-201. Mtg. 2. Hilton Head Island, SC. University of Iowa College of Medicine and University of Chicago Medical Center, Depts. of Pediatrics.
68. Giorgiani, G., Bozzola, M., Locatelli, F., Picco, P., Zecca, M., Cisternino, M., Dallorso, S., Bonetti, F., Dini, G., Borrone, C., Regazzi, M.B., De Stefano, P. and Severi, F. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 86, 825-31.
69. Olshan, J.S., Willi, S.M., Gruccio, D. and Moshang, T. (1993) Growth hormone function and treatment following bone marrow transplant for neuroblastoma. Bone Marrow Transplant. 12, 381-85.
70. Bozzola, M., Giorgiani, G., Locatelli, F., Cisternino, M., Gambarana, D., Zecca, M., Torcetta, F. and Severi, F. (1993) Growth in children after bone marrow transplantation. Horm. Res. 39, 122-36.
71. Ryalls, M., Spoudeas, H.A., Hindmarsh, P.C., Matthews, D.R., Tait, D.M., Meller, S.T. and Brook, C.G.D. (1993) Short-term endocrine consequences of total body irradiation and bone marrow transplantation in children treated for leukemia. J. Endocrinol. 136, 331-8.
72. Brauner, R., Fontoura, M., Zucker, J.M., Devergie, A., Souberbielle, J.C., Prevot-Saucet, C., Michon, J., Gluckman, E., Griscelli, C., Fischer, A. and Rappaport, R. (1993) Growth and growth hormone secretion after bone marrow transplantation. Arch. Dis. Child. 68, 458-63.
73. Ogilvy-Stuart, A.L., Clark, D.J., Wallace, W.H.B., Gibson, B.E., Stevens, R.F., Shalet, S.M. and Donaldson, M.D.C. (1992) Endocrine deficit after fractionated total body irradiation. Arch. Dis. Child. 67, 1107-10.
74. Thomas, B.C., Stanhope, R., Plowman, P.N. and Leiper, A.D. (1993) Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur. J. Pediatr. 152, 888-92.
75. Thomas, B.C., Stanhope, R., Plowman, P.N. and Leiper, A.D. (1993) Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood. Acta Endocrinol. 128, 508-12.
76. Huma, Z., Boulad, F., Black, P., Heller, G. and Sklar, C. (1995) Growth in children after bone marrow transplantation for acute leukemia. Blood 86, 819-24.
77. Bushhouse, S., Ramsay, N.K.C., Pescovitz, O.H., Kim, T. and Robison, L.L. (1989) Growth in children following irradiation for bone marrow transplantation. Am. J. Pediatr. Hematol-Oncol. 11, 134-40.
78. Saenger, P., Schwartz, E., Markenson, A.L., Graziano, J.H., Levine, L.S., New, M.I. and Hilgartner, M.W. (1980) Depressed serum somatomedin activity in β-thalassemia. J. Pediatr. 96, 214-8.
79. De Sanctis, V., Galimberti, M., Lucarelli, G., Polchi, P., Ruggiero, L. and Vullo, C. (1991) Gonadal function after allogeneic bone marrow transplantation for thalassemia. Arch. Dis. Child. 66, 517-20.
80. Shalet, S.M. (1989) Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J. Endocrinol. 120, 161-5.
81. Littley, M.D., Shalet, S.M., Morgenstern, G.R. and Deakin, D.P. (1991) Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Quart. J. Med. 287, 265-74.
82. Brauner, R., Czernichow, P., Cramer, P., Schaison, G. and Rappaport, R. (1983) Leydig cell function in children after direct testicular irradiation for acute lymphoblastic leukemia. N. Engl. J. Med. 309, 25-8.
83. Leiper, A.D., Grant, D.B. and Chessells, J.M. (1983) The effect of testicular irradiation on Leydig cell function in prepubertal boys with acute lymphoblastic leukemia. Arch. Dis. Child. 58, 906-10.
84. Shalet, S.M., Horner, A., Ahmed, S.R. and Morris-Jones, P.H. (1985) Leydig cell damage after testicular irradiation for lymphoblastic leukaemia. Med. Pediatr. Oncol. 13, 65-8.
85. Castillo, L.A., Craft, A.W., Kernahan, J., Evans, R.G.B. and Aynsley-Green, A. (1990) Gonadal function after 12 Gy testicular irradiation in childhood acute lymphoblastic leukæmia. Med. Pediatr. Oncol. 18, 185-9.
86. Spinelli, S., Chiodi, S., Bacigalupo, A., Brasca, A., Valenzano Menada, M., Petti, A.R., Ravera, G., Gualandi, F., VanLint, M.T., Sessarego, M., Frassoni, F., Occhini, D., Lamparelli, T., Valeriani, A., Oneto, R., Vitale, V., Corvo, R. and Marmont, A.M. (1994) Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow up of 79 females. Bone Marrow Transplant. 14, 373-80.
87. Chatterjee, R., Mills, W., Katz, M., McGarrigle, H.H. and Goldstone, A.H. (1994) Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogeneic transplantation in post-menarcheal female patients. Bone Marrow Transplant. 13, 511-7.
88. Critchley, H.O.D., Wallace, W.H.D., Mamtora, H., Higginson, J. and Anderson, D.C. (1992) Abdominal irradiation in childhood: the potential for pregnancy. Br. J. Obstet. Gynœcol. 99, 392-4.
89. Wallace, W.H.B., Shalet, S.M., Crowne, E.C., Morris-Jones, P.H. and Gattamaneni, H.R. (1989) Ovarian failure following abdominal irradiation in childhood: Natural history and prognosis. Clin. Oncol. 1, 75-9.
90. Li, F.P., Gimbrere, K., Gelber, R.D., Sallan, S.E., Flamant, F., Green, D.M., Heyn, R. and Meadows, A.T. (1987) Outcome of pregnancy in survivors of Wilms' tumor. JAMA 257, 216-9.
91. Lorini, R., Cortona, L., Scaramuzza, A., De Stefano, P., Bonetti, F. and Severi, F. (1994) Hyperinsulinemia in 34 children and adolescents after bone marrow transplantation, (abstr.) Hormone Res. 41, 63.
92. Lorini, R., Cortona, L., Scaramuzza, A., DeStefano, P., Locatelli, F., Bonetti, F. and Severi, F. (1995) Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant. 15, 873-7.
93. Sanders, J.E., Pritchard, S., Mahoney, P., Amos, D., Buckner, C.D., Witherspoon, R.P., Deeg, H.J., Doney, K.C., Sullivan, K.M., Appelbaum, F.R., Storb, R. and Thomas, E.D. (1986) Growth and development following marrow transplantation for leukemia. Blood 68, 1129-35.
94. Mascarin, M., Giavitto, M., Zanazzo, G.A., Andolina, M., Cova, M., Accorsi, E. and Tamaro, P. (1991) Avascular necrosis of bone in children undergoing allogeneic bone marrow transplantation. Cancer 68, 655.
95. Girinsky, T., Socie, G., Cosset, J.M. and Malaise, E.P. (1991) Blood lymphocyte subsets after the first fraction in patients given hyperfractionated total body irradiation for bone marrow transplantation. Br. J. Cancer 63, 646-7.
96. Van der Jagt, R.H.C., Appelbaum, F.R., Petersen, F.B., Bigelow, C.L., Fisher, L.D., Schoch, G.H., Buckner, C.D., Sanders, J.E., Storb, R., Sullivan, K.M. and Thomas, E.D. (1991) Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy. Bone Marrow Transplant. 8, 211-5.
97. Latini, P., Aristei, C., Aversa, F., Checcaglini, F., Maranzano, E., Raymondi, C., Panizza, B.M., Perrucci, E. and Martelli, M.F. (1991) Lung damage following bone marrow transplantation after hyperfractionated total body irradiation. Radiother. Oncol. 22, 127-32.
98. Kader, H.A., Khanna, S., Hutchinson, R.M., Aukett, R.J. and Archer, J. (1994) Pulmonary complications of bone marrow transplantation: The impact of variations in total body irradiation parameters. Clin. Oncol. 6, 96-101.
99. Arvidson, J., Bratteby, L.-E., Carlson, K., Hagberg, H., Kreuger, A., Simmonsson, B., Smedmyr, B., Taube, A., Öberg, G., Lönnerholm, G. (1994) Pulmonary function after autologous bone marrow transplantation in children. Bone Marrow Transplant. 14, 117-23.
100. Lee, C.-K., Gingrich, R.D., Hohl, R.J. and Ajram, K.A. (1995) Engraftment syndrome in autologous bone marrow and peripheral blood stem cell transplantation. Bone Marrow Transplant. 16, 175-82.
101. Truesdell, S., Schwartz, C., Clark, E. and Constine, L. (1994) Cardiovascular effects of cancer therapy. In C.L. Schwartz, W.L. Hobbie, L.S. Constine and K.S. Ruccione (eds) Survivors of Childhood Cancer: Assessment and Management, pp. 159-176. St. Louis: Mosby.
102. Dinndorf, P. and Bunin, N. (1995) Bone marrow transplantation for children with acute myelogenous leukemia. Am. J. Pediatr. Hematol. Oncol. 17, 211-24.
103. McDonald, G.B., Hinds, M.S., Fisher, L.D., Schoch, H.G., Wolford, J.L., Banaji, M., Hardin, B.J., Shulman, H.M. and Clift, R.A. (1993) Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann. Intern. Med. 118, 255-67.
104. Emminger, W., Emminger-Schmidmeier, W., Peters, C. and Gadner, H. (1991) Influence of immunosuppression on acute liver toxicity after intensified conditioning regimens for bone marrow transplantation in children. (letter) Blood 77, 1621.
105. Clift, R.A., Bianco, J.A., Appelbaum, F.R., Buckner, C.D., Singer, J.W., Bakke, L., Bensinger, W.I., Bowden, R.A., McDonald, G.B., Schubert, M., Shields, A.F., Slattens, J.T., Storb, R., Fisher, L.O., Mori, M., Thomas, E.D. and Hansen, J.A. (1993) A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation. Blood 82, 2025-30.
106. Cahn, J.Y., Flesch, M., Brion, A., Deconick, E., Leconte des Floris, M.F., Voillat, L., Plouvier, E., Amsallem, D., Tiberghien, P., Fest, T.R.A., Carbillet, J.P. and Herve, P. (1992) Prevention of veno-occlusive disease of the liver after bone marrow transplantation: Heparin or no heparin? Blood 80, 2149-50.
107. Gluckman, E., Jolivet, I., Scrobohaci, M.L., Devergie, A., Traineau, R., Bourdeau-Esperou, H., Lehn, P., Faure, P. and Drouet, L. (1990) Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukæmic patients treated by allogeneic bone marrow transplantation. Br. J. Hœmatol. 74, 277-81.
108. Bearman, S.I., Shen, D.D., Hinds, M.S., Hill, H.A. and McDonald, G.B. (1993) A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation. Br. J. Hœmatol. 84, 724-30.
109. Essell, J.H., Thompson, J.M., Harman, G.S., Halvorson, R.D., Snyder, M.J., Callander, N.S. and Clement, D.J. (1992) Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients. Bone Marrow Transplant. 10, 367-72.
110. Essell, J., Schroeder, M., Thompson, J., Harman, G., Halvorson, R. and Callander, N. (1994) A randomized, double-blind trial of prophylactic ursodeoxycholic acid vs. placebo to prevent venocclusive disease of the liver in patients undergoing allogeneic bone marrow transplantation (abstr.). Blood 84 (suppl 1), 250.
111. Richardson, P., Krishnan, A., Wheeler, C., Ayash, L., Hoppensteadt, D., Fareed, J., Schnipper, L., Kufe, D., Frei III, E. and Elias, A. (1995) The use of defibrotide in BMT-associated veno-occlusive disease (abstr. 870). Blood 80, 221a.
112. Blatt, J., Neigut, D., Robertson, J.M. and Lawrence, T.S. (1994) Late gastrointestinal and hepatic effects. In C.L. Schwartz, W.L. Hobbie, L.S. Constine and K.S. Ruccione (eds) Survivors of Childhood Cancer. pp. 197-211. St. Louis: Mosby.
113. Grochow, L.B., Krivit, W., Whitley, C.B. and Blazar, B. (1990) Busulfan distribution in children. Blood 75, 1723-7.
114. Grochow, L.B., Jones, R.J., Brundrett, R.B., Braine, H.G., Chen, T.L., Saral, R., Santos, G.W. and Colvin, O.M. (1989) Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother. Pharmacol. 25, 55-61.
115. Yeager, A.M., Wagner, J.E. Jr, Graham, M.L., Jones, R.J., Santos, G.W. and Grochow, L.B. (1992) Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation. Blood 80, 2425-8.
116. Grochow, L.B. (1993) Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens. Semin. Oncol. 204 (Suppl 4), 18-25.
117. Hassan, M., Ljungman, P., Bolme, P., Ringdén, O., Syruckova, Z., Békassy, A., Stary, J., Wallin, I. and Kållberg, N. (1994) Busulfan bioavailability. Blood 84, 2144-50.
118. Ehninger, G., Schuler, U., Renner, U., Ehrsam, M., Zeller, K.P., Blanz, J., Storb, R. and Deeg, H.J. (1995) Use of a water-soluble busulfan formulation-pharmacokinetic studies in a canine model. Blood 85, 3247-9.
119. Andersson, B.S., Madden, T., Hu, W., Chow, D., Vaughn, W.P., Blume, K., Williams, T.E. and Champlin, R.E. (1995) Phase one study of intravenous busulfan and cyclophosphamide as pretransplant conditioning therapy (abstr. 883). Blood 80, 219a.
120. Sankaranarayanan, K. and Chakraborty, R. (1995) Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. I. Background. Radiat. Res. 143, 121-43.
121. Land, C.E., Tokunaga, A. and Nakamura, N. (1993) Early-onset breast cancer in A-bomb survivors (letter). Lancet 342, 237.
122. Tokunaga, N., Land, C.E., Tokuoka, S., Nishimori, I., Soda, M. and Akiba, S. (1994) Incidence of female breast cancer among atomic bomb survivors. Radiat. Res. 138, 209-33.
123. Boice, Jr J.D., Harvey, E.B., Blettner, M., Stovall, M. and Flannery, J.T. (1992) Cancer in the contralateral breast after radiotherapy for breast cancer. N. Engl. J. Med. 326, 781-5.
124. Hancock, S.L., Tucker, M.A. and Hoppe, R.T. (1993) Breast cancer after treatment for Hodgkin's disease. J. Natl. Cancer Inst. 85, 25-31.
125. Draper, G.J., Sanders, B.M. and Kingston, J.E. (1986) Second primary neoplasms with retinoblastoma. Br. J. Cancer. 53, 661-71.
126. Roarty, J.D., McLean, I.W. and Zimmerman, L.E. (1988) Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology 95, 1583-7.
127. Kolb, H.J., Guenther, W., Duell, T., Socie, G., Schaeffer, E., Holler, E., Schumm, M., Horowitz, M.M., Gale, R.P. and Fliedner, T.M. (1992) Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects. Bone Marrow Transplant. 10 (suppl 1), 135-8.
128. Socie, G., Henry-Amar, M., Bacigalupo, A., Hows, J., Tichelli, A., Ljungman, P., McCann, S.R., Frickhofen, N., Van't Veer-Korthof, E. and Gluckman, E. (1993) Malignant tumors occurring after treatment of aplastic anemia. (European Bone Marrow Transplantation-Severe Aplastic Anemia Working Party). N. Engl. J. Med. 329, 1152-7.
129. Bloechle, C., Peiper, M., Schwarz, R., Schroeder, S. and Zornig, C. (1995) Post-irradiation soft tissue sarcoma. Eur. J. Cancer 31 A, 31-4.
130. Shank, B. (1994) Radiotherapeutic principles of bone marrow transplantation. In S.J. Forman, K.G. Blume and E.D. Thomas (eds) Bone Marrow Transplantation, chap. 9, pp. 96-113. Boston: Blackwell Scientific Publications.